{"id":"https://openalex.org/W2321399249","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","title":"Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)","display_name":"Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2321399249","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","mag":"2321399249"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.7586","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/22","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087541775","display_name":"Mansoor Noorali Saleh","orcid":"https://orcid.org/0000-0003-0209-8630","observed_orcids":["https://orcid.org/0000-0003-0209-8630"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. N. Saleh","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Socinski","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069416760","display_name":"David F. Trent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Trent","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035192409","display_name":"Thomas E. Dobbs","orcid":"https://orcid.org/0000-0001-6199-5337","observed_orcids":["https://orcid.org/0000-0001-6199-5337"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Dobbs","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013680064","display_name":"Lee M. Zehngebot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. M. Zehngebot","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102728172","display_name":"Michelle Levine","orcid":"https://orcid.org/0000-0002-7252-3666","observed_orcids":["https://orcid.org/0000-0002-7252-3666"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. A. Levine","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037503098","display_name":"Philip J. Stella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1292069884","display_name":"Greater Baltimore Medical Center","ror":"https://ror.org/0077fnc39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1292069884"]},{"id":"https://openalex.org/I4210085997","display_name":"Florida Hospital Cancer Institute","ror":"https://ror.org/00aqz8k66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210085997"]},{"id":"https://openalex.org/I4210098033","display_name":"Virginia Cancer Institute","ror":"https://ror.org/00st10j60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098033"]},{"id":"https://openalex.org/I4210104194","display_name":"Tennessee Cancer Specialists","ror":"https://ror.org/01krbfc31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210104194"]},{"id":"https://openalex.org/I4210156026","display_name":"Georgia Cancer Specialists","ror":"https://ror.org/057c61d28","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210156026"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. J. Stella","raw_affiliation_strings":["Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Cancer Specialists, Marietta, GA; University of North Carolina, Chapel Hill, NC; Virginia Cancer Institute, Richmond, VA; Tennessee Cancer Specialists, Knoxville, TN; Florida Hospital Cancer Institute, Orlando, FL; Greater Baltimore Medical Center, Baltimore, MD; Ann Arbor Hematology Oncology, Ann Arbor, MI","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1292069884","https://openalex.org/I4210085997","https://openalex.org/I4210098033","https://openalex.org/I4210104194","https://openalex.org/I4210156026"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"7586","last_page":"7586"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9700000286102295},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/dose-schedule-comparison","display_name":"dose schedule comparison","score":0.8420000076293945},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9020000100135803},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9367069005966187},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9089717268943787},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8310486674308777},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.638387143611908},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6284388303756714},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5780016183853149},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4644226133823395},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4532443583011627},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4455568790435791},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.44389113783836365},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.43197566270828247},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4284837543964386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3244559168815613},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1844763457775116},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11858683824539185}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.7586","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7586","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:ecommons.aku.edu:eastafrica_fhs_mc_haematol_oncol-1021","doi":null,"is_oa":true,"landing_page_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/22","pdf_url":null,"source":{"id":"https://openalex.org/S4377196301","display_name":"eCommons - AKU (Aga Khan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118185606","host_organization_name":"Aga Khan University","host_organization_lineage":["https://openalex.org/I118185606"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematology and Oncology, East Africa","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:ecommons.aku.edu:eastafrica_fhs_mc_haematol_oncol-1021","doi":null,"is_oa":true,"landing_page_url":"https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/22","pdf_url":null,"source":{"id":"https://openalex.org/S4377196301","display_name":"eCommons - AKU (Aga Khan University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118185606","host_organization_name":"Aga Khan University","host_organization_lineage":["https://openalex.org/I118185606"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Haematology and Oncology, East Africa","raw_type":"text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142042045","https://openalex.org/W2607358647","https://openalex.org/W2275177970","https://openalex.org/W1972473164","https://openalex.org/W2120612535","https://openalex.org/W2286278842","https://openalex.org/W2081714604","https://openalex.org/W3080436544","https://openalex.org/W2244058194","https://openalex.org/W2343670117"],"abstract_inverted_index":{"7586":[0],"Background:":[1],"Cetuximab,":[2],"an":[3,223],"IgG1":[4],"monoclonal":[5],"antibody":[6],"targeting":[7],"the":[8,173],"epidermal":[9],"growth":[10],"factor":[11],"receptor":[12],"(EGFR)":[13],"on":[14,88,97,112],"both":[15,83,217],"normal":[16],"and":[17,30,49,91,106,127,172,194,203,214,222,233],"tumor":[18],"cells,":[19],"has":[20,187],"been":[21],"investigated":[22],"in":[23,31,44,54,82,216,227],"advanced":[24],"NSCLC":[25],"as":[26],"a":[27,100,113,119],"single":[28],"agent":[29],"combination":[32,45],"with":[33,46,61,118,190,212,229],"chemotherapy.":[34],"This":[35],"ongoing":[36],"randomized":[37,71,193],"phase":[38],"II":[39],"open-label":[40],"trial":[41],"evaluates":[42],"cetuximab":[43,154],"carboplatin":[47],"(Cb)":[48],"paclitaxel":[50],"(Pac)":[51],"when":[52],"given":[53,111,132],"two":[55],"dose":[56,218],"schedules":[57,219],"to":[58,72,166,243],"patients":[59],"(pts)":[60],"previously":[62],"untreated":[63],"stage":[64],"IIIB/IV":[65],"NSCLC.":[66,230],"Methods:":[67],"Eligible":[68],"pts":[69,192,202,228],"were":[70,165],"1":[73,90],"of":[74,102,121,137],"2":[75],"treatment":[76,79],"arms.":[77],"Cetuximab":[78,210],"was":[80,116],"identical":[81],"arms:":[84],"400":[85],"mg/m2":[86,93,109,130],"IV":[87,105,110,124,131],"day":[89,98],"250":[92],"weekly":[94,133,153],"thereafter.":[95],"Beginning":[96],"8,":[99],"schedule":[101,120],"Cb":[103,122,213],"AUC=6":[104,123],"Pac":[107,128,215],"225":[108],"3-week":[114],"cycle":[115],"compared":[117],"q4":[125],"weeks":[126,136],"100":[129],"for":[134,200,206],"3":[135],"each":[138],"4-week":[139],"cycle.":[140],"Pts":[141],"who":[142],"achieve":[143],"CR,":[144],"PR,":[145],"or":[146,159],"SD":[147],"after":[148],"4":[149],"cycles":[150],"may":[151],"continue":[152],"monotherapy":[155],"until":[156],"disease":[157],"progression":[158],"unacceptable":[160],"toxicity.":[161],"The":[162,185],"primary":[163],"objectives":[164,180],"estimate":[167],"median":[168],"progression-free":[169],"survival":[170,235],"(PFS)":[171],"PFS":[174,232],"rate":[175],"at":[176],"6":[177],"months.":[178],"Secondary":[179],"included":[181],"response":[182],"rate.":[183],"Results:":[184],"study":[186],"completed":[188],"accrual,":[189],"168":[191],"165":[195],"treated.":[196],"Data":[197],"are":[198,237],"available":[199],"164":[201],"confirmed":[204],"responses":[205],"155":[207],"pts.":[208],"Conclusions:":[209],"combined":[211],"demonstrated":[220],"activity":[221],"acceptable":[224],"toxicity":[225],"profile":[226],"Final":[231],"overall":[234],"data":[236],"pending.":[238],"No":[239],"significant":[240],"financial":[241],"relationships":[242],"disclose.":[244],"[Table:":[245],"see":[246],"text]":[247]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}